Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–15 of 15 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07475806
- Conditions
- Muscle-invasive Bladder Cancer
- Locations
-
- Arkansas Urology Associates Little Rock, Arkansas, United States
- University of Illinois College of Medicine - UIC Cancer Center Chicago, Illinois, United States
- Accellacare of Duly Lisle, Illinois, United States
- NYU Langone Urology Associates New York, United States
Recruiting
mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer
NCT06335667
- Conditions
- Muscle-invasive Bladder Cancer, Urothelial Bladder Cancer
- Locations
-
- Chao Family Comprehensive Cancer Center University of California, Irvine Orange, California, United States
NCT06682728
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Muscle-invasive Bladder Cancer, +4 more
- Locations
-
- Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States
NCT05779631
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Jeroen Bosch ziekenhuis 's-Hertogenbosch, Netherlands
- Ziekenhuisgroep Twente Almelo, Netherlands
- Meander MC Amersfoort, Netherlands
- Amsterdam UMC, location AMC Amsterdam, Netherlands
NCT06511648
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Muscle-invasive Bladder Cancer, +3 more
- Locations
-
- CLCC Jean Perrin Clermont-Ferrand, France
- CLCC Léon Bérard Lyon, France
- Institut Mutualiste Montsouris Paris, France
- IUCT Toulouse, France
NCT06373055
- Conditions
- Muscle-invasive Bladder Cancer
- Locations
-
- Department of Urology and Urological Science Institute, Yonsei University College of Medicine Seoul, Republic of Korea Seoul, South Korea
Not Yet Recruiting
Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy
NCT07440901
- Conditions
- Muscle-invasive Bladder Cancer
- Locations
-
Not specified
Not Yet Recruiting
Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
NCT06957561
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Not Yet Recruiting
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
NCT06686381
- Conditions
- Muscle-invasive Bladder Cancer
- Locations
-
- American University of Beirut Beirut, Lebanon
NCT05945108
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
- Locations
-
- Research Site Belo Horizonte, Brazil
- Research Site Porto Alegre, Brazil
- Research Site Recife, Brazil
- Research Site Salvador, Brazil
NCT02462239
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Juravinski Cancer Centre Hamilton, Ontario, Canada
- London Regional Cancer Centre London, Ontario, Canada
- Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada
- Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada
- Conditions
- Bladder Cancer, Bladder Tumor, Female Urogenital Diseases, +11 more
- Locations
-
- Local Institution - 0080 Gilbert, Arizona, United States
- Local Institution - 0136 Tucson, Arizona, United States
- Local Institution - 0029 La Jolla, California, United States
- Local Institution - 0015 Orange, California, United States
Completed
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
NCT00808639
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Lahey Clinic Burlington, Massachusetts, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
NCT03661320
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Local Institution - 0022 Tucson, Arizona, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
- Local Institution - 0021 Littleton, Colorado, United States
- Local Institution - 0036 Pensacola, Florida, United States
Active, Not Recruiting
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy
NCT04660344
- Conditions
- Muscle-invasive Bladder Cancer
- Locations
-
- Cancer Care Centers of Brevard Rockledge, Florida, United States
- Optum Health Care Las Vegas, Nevada, United States
- Cleveland Clinic Cleveland, Ohio, United States
- AHN Cancer Institute ? Allegheny General Hospital Pittsburgh, Pennsylvania, United States